Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V mit dem Wirkstoff Betamethason in den Darreichungsformen CRE, EMU, SAL und LOE

TENDER DESCRIPTION

GWQ ServicePlus AG intends to conclude non-exclusive discount agreements pursuant to Section 130a(8) of SGB V for the above-mentioned active ingredient with a contract start date of 01.01.2027. At any time during the term of the contract, all interested companies may accede to this contract on the same terms (admission model). GWQ assumes that, due to the absence of a selection decision and thus the non-discriminatory access opportunity for all pharmaceutical companies, this procedure does not fall within the scope of cartel procurement law. The contract documents, the participating health insurance funds and their revenues, as well as the dates for notification of the contract, can be viewed and downloaded on the procurement portal of GWQ ServicePlus AG at https://vergabeportal.gwq-serviceplus.de/arzneimittel. Until the start of exclusive contracts, this transitional arrangement is open to all market participants for accession. If the signed contracts / declarations and evidence are received by 10.12.2026, an initial notification for 01.01.2027 can be implemented. The following documents must be submitted: signed contract in duplicate; evidence of marketing authorisation under…

TENDER BRIEF

TENDER DOCUMENTS